✦ LIBER ✦

A Randomized Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Efficacy and Safety of Two Doses of the Tramadol Orally Disintegrating Tablet for the Treatment of Premature Ejaculation Within Less Than 2 Minutes

✍ Scribed by David Bar-Or; Kristin M. Salottolo; Alessandro Orlando; James V. Winkler

Book ID: 113612497
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 763 KB
Volume: 61
Category: Article
ISSN: 0302-2838
DOI: 10.1016/j.eururo.2011.08.039

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Re: David Bar-Or, Kristin M. Salottolo,

Re: David Bar-Or, Kristin M. Salottolo, Alessandro Orlando, James V. Winkler. A Randomized Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Efficacy and Safety of Two Doses of the Tramadol Orally Disintegrating Tablet for the Treatment of Premature Ejaculation Within Less Than 2 Minutes. Eur Urol 2012;61:736–43

✍ Christopher C.K. Ho 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 73 KB

Reply to Christopher C.K. Ho's Letter to

Reply to Christopher C.K. Ho's Letter to the Editor re: David Bar-Or, Kristin M. Salottolo, Alessandro Orlando, James V. Winkler. A Randomized Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Efficacy and Safety of Two Doses of the Tramadol Orally Disintegrating Tablet for the Treatment of Premature Ejaculation Within Less Than 2 Minutes. Eur Urol 2012;61:736–43

✍ David Bar-Or; Kristin M. Salottolo 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 74 KB

Safety and efficacy of citalopram in the

Safety and efficacy of citalopram in the treatment of premature ejaculation: a double-blind placebo-controlled, fixed dose, randomized study

✍ Safarinejad, M R; Hosseini, S Y 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 100 KB

POD-05.03: Safety and efficacy of escita

POD-05.03: Safety and efficacy of escitalopram in the treatment of premature ejaculation: a double blind placebo-controlled, fixed dose, randomized study

✍ M.R. Safarinejad 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 59 KB

A multicentre, randomized, double-blind,

A multicentre, randomized, double-blind, placebo-controlled study to evaluate the efficacy, tolerability and safety of two doses of metrifonate in patients with mild-to-moderate Alzheimer's disease: the MALT study

✍ Bruno Dubois; Ian McKeith; Jean-Marc Orgogozo; Owen Collins; Didier Meulien 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB 👁 3 views

Background. Metrifonate is a long-lasting acetylcholinesterase inhibitor being developed for the symptomatic treatment of Alzheimer's disease (AD). Objectives. This study compared the ecacy, tolerability and safety of two doses of metrifonate in patients with mild-to-moderate AD, over a 26-week tre

Randomized, multicenter, double-blind, p

Randomized, multicenter, double-blind, placebo-controlled trial to evaluate the efficacy and safety of synthetic conjugated estrogens B for the treatment of vulvovaginal atrophy in healthy postmenopausal women

✍ James A. Simon; Kathleen Z. Reape; Steve Wininger; Howard Hait 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 542 KB